1. Home
  2. ALDX vs TBN Comparison

ALDX vs TBN Comparison

Compare ALDX & TBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • TBN
  • Stock Information
  • Founded
  • ALDX 2004
  • TBN 2009
  • Country
  • ALDX United States
  • TBN Australia
  • Employees
  • ALDX N/A
  • TBN N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • TBN
  • Sector
  • ALDX Health Care
  • TBN
  • Exchange
  • ALDX Nasdaq
  • TBN NYSE
  • Market Cap
  • ALDX 319.4M
  • TBN 268.4M
  • IPO Year
  • ALDX 2014
  • TBN 2024
  • Fundamental
  • Price
  • ALDX $4.85
  • TBN $17.25
  • Analyst Decision
  • ALDX Strong Buy
  • TBN Buy
  • Analyst Count
  • ALDX 2
  • TBN 3
  • Target Price
  • ALDX $10.00
  • TBN $34.67
  • AVG Volume (30 Days)
  • ALDX 571.6K
  • TBN 19.3K
  • Earning Date
  • ALDX 11-07-2024
  • TBN 11-12-2024
  • Dividend Yield
  • ALDX N/A
  • TBN N/A
  • EPS Growth
  • ALDX N/A
  • TBN N/A
  • EPS
  • ALDX N/A
  • TBN N/A
  • Revenue
  • ALDX N/A
  • TBN N/A
  • Revenue This Year
  • ALDX N/A
  • TBN N/A
  • Revenue Next Year
  • ALDX $25.36
  • TBN N/A
  • P/E Ratio
  • ALDX N/A
  • TBN N/A
  • Revenue Growth
  • ALDX N/A
  • TBN N/A
  • 52 Week Low
  • ALDX $2.43
  • TBN $16.47
  • 52 Week High
  • ALDX $6.55
  • TBN $25.99
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 45.59
  • TBN N/A
  • Support Level
  • ALDX $4.66
  • TBN N/A
  • Resistance Level
  • ALDX $5.01
  • TBN N/A
  • Average True Range (ATR)
  • ALDX 0.40
  • TBN 0.00
  • MACD
  • ALDX -0.01
  • TBN 0.00
  • Stochastic Oscillator
  • ALDX 46.06
  • TBN 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About TBN TAMBORAN RESOURCES CORPORATION

Tamboran Resources Corp is a gas company focused on supporting the Net Zero CO2 energy transition in Australia and Asia-Pacific through developing low CO2 unconventional gas resources in the Australian Northern Territory.

Share on Social Networks: